Sunrise gains FDA clearance for rechargeable at-home sleep diagnostic device

Sunrise has received FDA clearance for Sunrise Air, a rechargeable chin-worn device that monitors mandibular jaw movement alongside airflow, oxygen saturation, heart rate, and snoring analysis through an embedded microphone. The system applies AI-supported algorithms to generate clinical sleep reports, with multi-night recharging capability eliminating the friction of disposable components in traditional home testing. Obstructive sleep apnea affects over 900 million people globally, and Sunrise claims its additional sensors strengthen respiratory event detection while distinguishing central from obstructive apneas in clinically complex cases. The device carries peer-reviewed validation, iF Design recognition, and integrates with Dreem Health, a virtual sleep clinic covered by major U.S. insurers across all 50 states. For the longevity-focused reader, this represents clinically rigorous diagnostics without sleep laboratory friction—expanding access to medical-grade preventive monitoring as part of comprehensive health intelligence.